바이오의약품 및 생물의약품 시장 : 제품 유형별, 용도별, 치료 분야별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 및 예측(2024-2032년)

REPORT HIGHLIGHT

Biopharmaceutical and Biomedicine Market size was valued at USD 621,312 Million in 2023, expanding at a CAGR of 9.5% from 2024 to 2032.

The biopharmaceutical and biomedicine market encompasses the development, production, and commercialization of pharmaceuticals and medical products derived from biological sources. The growing adoption of precision medicine and personalized therapies, advancements in biotechnology such as gene editing and cell therapy, and increased focus on rare diseases and orphan drugs. However, restraints in the biopharmaceutical and biomedicine market include stringent regulatory requirements, high research and development costs, and challenges related to manufacturing and scaling up production. Opportunities abound in emerging markets, expansion into therapeutic areas with unmet medical needs, and strategic collaborations and partnerships for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Market Dynamics

Surging rates of product launches and approvals in the biopharmaceuticals and biomedicines sector

The biopharmaceuticals and biomedicines sector is witnessing a notable surge in rates of product launches and approvals, indicative of the industry's rapid innovation and expansion. According to data from the U.S. Food and Drug Administration (FDA), there has been a steady increase in the number of biopharmaceutical products receiving regulatory approval in recent years, with a record number of new drug approvals reported annually. This trend underscores the industry's commitment to addressing unmet medical needs and improving patient outcomes through the development of groundbreaking biopharmaceutical and biomedicine products.

Biopharmaceutical and Biomedicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.5% over the forecast period (2024-2032)

Based on product type segmentation, Monoclonal Antibodies were predicted to show maximum market share in the year 2023

Based on application segmentation, Therapeutics was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Biopharmaceutical and Biomedicine Market- Segmentation Analysis:

The Global Biopharmaceutical and Biomedicine Market is segmented based on Product Type, Application, Therapeutic Area, and Region.

The market is divided into two categories based on product type: Monoclonal Antibodies widely used in therapeutic applications such as cancer treatment and autoimmune diseases. Nanomedicine is for diagnosing, treating, and preventing diseases at the molecular level, offering targeted delivery and enhanced efficacy in drug delivery and imaging applications.

The market is divided into three categories based on application: Utilized for treating diseases and medical conditions. Diagnostics are used for identifying and diagnosing diseases or conditions. Research and Development are applied in scientific research and experimental studies for drug discovery and development.

Biopharmaceutical and Biomedicine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

North America and Europe stand as key players, boasting advanced healthcare infrastructure, robust research and development capabilities, and favorable regulatory environments. Meanwhile, the Asia-Pacific region demonstrates significant growth potential, driven by rising healthcare expenditures, increasing prevalence of chronic diseases, and expanding access to innovative therapies. Latin America and the Middle East & Africa regions also present opportunities for market expansion, albeit with challenges related to healthcare infrastructure, affordability, and regulatory complexities.

Biopharmaceutical and Biomedicine Market- Competitive Landscape:

Several key players vie for dominance through strategies such as research and development investments, mergers and acquisitions, and strategic partnerships. Companies including Roche, Pfizer, and Johnson & Johnson lead the market with diverse portfolios of biopharmaceutical products and extensive global reach. Additionally, innovative biotechnology firms such as Amgen, Biogen, and Gilead Sciences contribute to market competitiveness with groundbreaking therapies and novel drug candidates. As competition intensifies, companies focus on differentiation through product innovation, regulatory approvals, and market expansion efforts.

Recent Developments:

In May 2022, JSR Life Sciences unveiled a new business division called Similis Bio, aimed at collaborating with biopharmaceutical firms to enhance efficiency and lower costs associated with biosimilar development.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Amgen Inc.

F. Hoffmann-La Roche Ltd

Johnson & Johnson Services, Inc.

Pfizer Inc.

Sanofi

Eli Lilly and Company

AbbVie Inc.

Novo Nordisk A/S

Bristol-Myers Squibb Company

NanoString

QIAGEN

Affimed GmbH

GSK plc.

Merck KgaA

Teva Pharmaceutical Industries Ltd.

Others

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

• Monoclonal Antibodies
• Vaccines
• Recombinant Human Insulin
• Human Growth Hormone
• Erythropoietin
• Interferon
• Others
• Nanomedicine
• Cell & Gene Therapy
• Bioinformatics
• Molecular Enzymes & Kits

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Therapeutics
• Diagnostics
• Research and Development

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

• Oncology
• Neurology
• Cardiology
• Immunology
• Infectious Diseases
• Rare Diseases

GLOBAL BIOPHARMACEUTICAL AND BIOMEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Biopharmaceutical and Biomedicine Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Biopharmaceutical and Biomedicine Market Snippet by Product Type
  • 2.1.2.Biopharmaceutical and Biomedicine Market Snippet by Application
  • 2.1.3.Biopharmaceutical and Biomedicine Market Snippet by Therapeutic Area
  • 2.1.4.Biopharmaceutical and Biomedicine Market Snippet by Country
  • 2.1.5.Biopharmaceutical and Biomedicine Market Snippet by Region
• 2.2.Competitive Insights

3.Biopharmaceutical and Biomedicine Key Market Trends

• 3.1.Biopharmaceutical and Biomedicine Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Biopharmaceutical and Biomedicine Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Biopharmaceutical and Biomedicine Market Opportunities
• 3.4.Biopharmaceutical and Biomedicine Market Future Trends

4.Biopharmaceutical and Biomedicine Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Biopharmaceutical and Biomedicine Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Biopharmaceutical and Biomedicine Market Landscape

• 6.1.Biopharmaceutical and Biomedicine Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Biopharmaceutical and Biomedicine Market - By Product Type

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
  • 7.1.2.Monoclonal Antibodies
    • 7.1.2.1.Vaccines
    • 7.1.2.2.Recombinant Human Insulin
    • 7.1.2.3.Human Growth Hormone
    • 7.1.2.4.Erythropoietin
    • 7.1.2.5.Interferon
    • 7.1.2.6.Others
  • 7.1.3.Nanomedicine
    • 7.1.3.1.Cell & Gene Therapy
    • 7.1.3.2.Bioinformatics
    • 7.1.3.3.Molecular Enzymes & Kits

8.Biopharmaceutical and Biomedicine Market - By Application

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2.Therapeutics
  • 8.1.3.Diagnostics
  • 8.1.4.Research and Development

9.Biopharmaceutical and Biomedicine Market - By Therapeutic Area

• 9.1.Overview
  • 9.1.1.Segment Share Analysis, By Therapeutic Area, 2023 & 2032 (%)
  • 9.1.2.Oncology
  • 9.1.3.Neurology
  • 9.1.4.Cardiology
  • 9.1.5.Immunology
  • 9.1.6.Infectious Diseases
  • 9.1.7.Rare Diseases

10.Biopharmaceutical and Biomedicine Market- By Geography

• 10.1.Introduction
  • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2.North America
  • 10.2.1.Overview
  • 10.2.2.Biopharmaceutical and Biomedicine Key Manufacturers in North America
  • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6.North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.2.7.U.S.
    • 10.2.7.1.Overview
    • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5.U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.2.8.Canada
    • 10.2.8.1.Overview
    • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5.Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
• 10.3.Europe
  • 10.3.1.Overview
  • 10.3.2.Biopharmaceutical and Biomedicine Key Manufacturers in Europe
  • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6.Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.7.Germany
    • 10.3.7.1.Overview
    • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5.Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.8.Italy
    • 10.3.8.1.Overview
    • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5.Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.9.United Kingdom
    • 10.3.9.1.Overview
    • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5.United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.10.France
    • 10.3.10.1.Overview
    • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5.France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.11.Russia
    • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.4.Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.12.Netherlands
    • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.4.Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.13.Sweden
    • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.4.Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.14.Poland
    • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.4.Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.3.15.Rest of Europe
    • 10.3.15.1.Overview
    • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5.Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
• 10.4.Asia Pacific (APAC)
  • 10.4.1.Overview
  • 10.4.2.Biopharmaceutical and Biomedicine Key Manufacturers in Asia Pacific
  • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6.Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.7.India
    • 10.4.7.1.Overview
    • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5.India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.8.China
    • 10.4.8.1.Overview
    • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5.China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.9.Japan
    • 10.4.9.1.Overview
    • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5.Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.10.South Korea
    • 10.4.10.1.Overview
    • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5.South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.11.Australia
    • 10.4.11.1.Overview
    • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5.Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.12.Thailand
    • 10.4.12.1.Overview
    • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5.Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.13.Indonesia
    • 10.4.13.1.Overview
    • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5.Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.14.Philippines
    • 10.4.14.1.Overview
    • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5.Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.4.15.Rest of APAC
    • 10.4.15.1.Overview
    • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5.Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
• 10.5.Latin America
  • 10.5.1.Overview
  • 10.5.2.Biopharmaceutical and Biomedicine Key Manufacturers in Latin America
  • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6.Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.5.7.Brazil
    • 10.5.7.1.Overview
    • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5.Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.5.8.Mexico
    • 10.5.8.1.Overview
    • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5.Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.5.9.Argentina
    • 10.5.9.1.Overview
    • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5.Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.5.10.Colombia
    • 10.5.10.1.Overview
    • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5.Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.5.11.Rest of LATAM
    • 10.5.11.1.Overview
    • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5.Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
• 10.6.Middle East and Africa
  • 10.6.1.Overview
  • 10.6.2.Biopharmaceutical and Biomedicine Key Manufacturers in Middle East and Africa
  • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6.Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.6.7.Saudi Arabia
    • 10.6.7.1.Overview
    • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5.Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.6.8.United Arab Emirates
    • 10.6.8.1.Overview
    • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5.United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.6.9.Israel
    • 10.6.9.1.Overview
    • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5.Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.6.10.Turkey
    • 10.6.10.1.Overview
    • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5.Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.6.11.Algeria
    • 10.6.11.1.Overview
    • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5.Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.6.12.Egypt
    • 10.6.12.1.Overview
    • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5.Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
  • 10.6.13.Rest of MEA
    • 10.6.13.1.Overview
    • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5.Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Biopharmaceutical and Biomedicine Industry

• 11.1.Competitive Dashboard
• 11.2.Company Profiles
  • 11.2.1.Amgen Inc.
  • 11.2.2.F. Hoffmann-La Roche Ltd
  • 11.2.3.Johnson & Johnson Services, Inc.
  • 11.2.4.Pfizer Inc.
  • 11.2.5.Sanofi
  • 11.2.6.Eli Lilly and Company
  • 11.2.7.AbbVie Inc.
  • 11.2.8.Novo Nordisk A/S
  • 11.2.9.Bristol-Myers Squibb Company
  • 11.2.10.NanoString
  • 11.2.11.QIAGEN
  • 11.2.12.Affimed GmbH
  • 11.2.13.GSK plc.
  • 11.2.14.Merck KgaA
  • 11.2.15.Teva Pharmaceutical Industries Ltd.
  • 11.2.16.Others

12.360 Degree Analyst View

13.Appendix

• 13.1.Research Methodology
• 13.2.References
• 13.3.Abbreviations
• 13.4.Disclaimer
• 13.5.Contact Us